<!DOCTYPE html><html><head><meta name="viewport" content="width=device-width, initial-scale=1.0"><style>html, body {margin: 0;padding: 0;width: 100%;} table {width: 100%; table-layout:auto;} body {max-width: 100%;overflow-x: hidden;padding: 0 10px;}</style><div style="position: relative;"><body dir="ltr" lang="en-US" link="#000080" vlink="#800000"><p style="line-height: 0.02in; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>
</p>
<p align="right" style="line-height: 100%; orphans: 2; widows: 2; margin-right: 0.26in; margin-top: 0.03in; margin-bottom: 0.06in">
<img align="bottom" border="0" height="59" hspace="12" name="Picture 1" src="data:image/png;base64,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" width="140"/>
</p>
<table cellpadding="0" cellspacing="0" style="width: 100%;" width="751">
<col width="375"/>
<col width="375"/>
<tbody>
<tr>
<td bgcolor="#0071c5" colspan="2" height="65" style="background: #0071c5; border-top: 1.00pt solid #000000; border-bottom: 1.00pt solid #000000; border-left: none; border-right: none; padding: 0in" valign="top"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-right: 2.2in">
<font color="#ffffff"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Clinical
				Guideline </span></span></font></font></font><br/>
<font color="#ffffff"><font face="Arial,Bold, serif"><font size="5" style="font-size: 20pt"><span style="font-style: normal"><b>BASIC
				ACUTE PAIN MANAGEMENT</b></span></font></font></font></p>
</td>
</tr>
</tbody>
<tbody>
<tr valign="top">
<td height="36" style="border-top: 1.00pt solid #000000; border-bottom: none; border-left: none; border-right: none; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-top: 0.14in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>SETTING</b></span></font></font></font></p>
</td>
<td style="border-top: 1.00pt solid #000000; border-bottom: none; border-left: none; border-right: none; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.28in; margin-top: 0.14in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">University
				Hospitals Bristol and Weston NHS Foundation Trust </span></span></font></font></font><font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>excluding</b></span></font></font></font></p>
</td>
</tr>
<tr>
<td colspan="2" height="27" style="border: none; padding: 0in" valign="top"><p align="left" style="orphans: 0; widows: 0; margin-left: 1.52in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>maternity,
				children’s services and Supportive &amp; Palliative care
				service.</b></span></font></font></font></p>
</td>
</tr>
<tr valign="top">
<td height="35" style="border: none; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-top: 0.07in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>FOR
				STAFF</b></span></font></font></font></p>
</td>
<td style="border: none; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.28in; margin-top: 0.08in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">All
				staff</span></span></font></font></font></p>
</td>
</tr>
<tr valign="top">
<td height="33" style="border: none; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-top: 0.07in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>PATIENTS</b></span></font></font></font></p>
</td>
<td style="border: none; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.28in; margin-top: 0.08in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Adult
				patients</span></span></font></font></font></p>
</td>
</tr>
</tbody>
</table>
<p align="center" style="line-height: 119%; orphans: 2; widows: 2; margin-top: 0.09in; margin-bottom: 0in">
<font color="#0071c5"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">________________________________________________________________________________
</span></span></font></font></font>
</p>
<p align="left" style="line-height: 0.3in; orphans: 2; widows: 2; margin-left: 0.2in; margin-top: 0.18in; margin-bottom: 0in">
<font color="#0071c5"><font face="Arial,Bold, serif"><font size="4" style="font-size: 16pt"><span style="font-style: normal"><b>ACUTE
PAIN SCORING </b></span></font></font></font>
</p>
<p align="left" style="line-height: 107%; orphans: 2; widows: 2; margin-left: 0.2in; margin-right: 0.3in; margin-top: 0.13in; margin-bottom: 0in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">The
clinician, the registered nurse, and all other healthcare providers
have a responsibility to work collaboratively in assessing each
individual patients needs in order to establish and implement a safe
and appropriate pain management plan to provide optimum pain relief. </span></span></font></font></font>
</p>
<p align="justify" style="line-height: 107%; orphans: 2; widows: 2; margin-left: 0.2in; margin-right: 0.48in; margin-top: 0.13in; margin-bottom: 0in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">The
below pain scoring tools are to be used with the modified World
Health Organisation (WHO) Analgesic ladder (found on the NEWS
observation chart). The ladder is designed to facilitate the
consideration of pharmacological and non-pharmacological techniques
for the relief of pain. </span></span></font></font></font>
</p>
<p align="left" style="line-height: 107%; orphans: 2; widows: 2; margin-left: 0.2in; margin-right: 0.3in; margin-top: 0.13in; margin-bottom: 0in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">All
adult patients admitted to the University Hospitals Bristol and
Weston NHS Foundation Trust Hospitals will have their pain assessed,
monitored and recorded using the Pain Assessment Tools provided in
the UHBW NEWS chart. </span></span></font></font></font>
</p>
<p align="left" style="line-height: 0.19in; orphans: 2; widows: 2; margin-left: 0.45in; margin-right: 0.4in; margin-top: 0.18in; margin-bottom: 0in">
<font color="#000000"></font><font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Visual/Verbal
Analogue Scale (VAS) </b></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">for
the cognitively able. The patient will be asked to </span></span></font></font></font> <font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">score
their pain, at rest and on movement, from 0 (no pain) to10 (severe
pain). </span></span></font></font></font>
</p>
<p align="left" style="line-height: 0.19in; orphans: 2; widows: 2; margin-left: 0.69in; margin-right: 0.2in; text-indent: -0.25in; margin-top: 0.04in; margin-bottom: 0in">
<font color="#000000"></font><font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>The
Abbey Scale </b></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">for
all patients who are unable to clearly articulate their needs e.g.
patients with a diagnosis of dementia (any stage) or any other
cognitive impairment. The patient is observed and scored 0 - 3 in six
elements at rest and on movement. The scores in the six elements are
added to represent a total pain score. </span></span></font></font></font>
</p>
<p align="left" style="line-height: 0.19in; orphans: 2; widows: 2; margin-left: 0.41in; margin-top: 0.32in; margin-bottom: 0in">
<font color="#000000"><font face="Arial, serif"><font size="2" style="font-size: 10pt"><span style="font-style: normal"><span style="font-weight: normal">For
full prescribing details and interactions, please refer to British
National Formulary (BNF) or the </span></span></font></font></font><font color="#0000ff"><font face="Arial,Italic, serif"><font size="2" style="font-size: 10pt"><i><span style="font-weight: normal">Electronic
</span></i></font></font></font>
</p>
<p align="left" style="line-height: 0.19in; orphans: 2; widows: 2; margin-left: 1.01in; margin-bottom: 0in">
<font color="#0000ff"><font face="Arial,Italic, serif"><font size="2" style="font-size: 10pt"><i><span style="font-weight: normal">Medicines
Compendium; Summary Product Characteristics (SPC) </span></i></font></font></font><font color="#000000"><font face="Arial, serif"><font size="2" style="font-size: 10pt"><span style="font-style: normal"><span style="font-weight: normal">for
further information. </span></span></font></font></font>
</p>
<p align="left" style="line-height: 0.3in; orphans: 2; widows: 2; margin-left: 0.2in; margin-top: 0.08in; margin-bottom: 0.15in">
<font color="#0071c5"><font face="Arial,Bold, serif"><font size="4" style="font-size: 16pt"><span style="font-style: normal"><b>NON-OPIOID
ANALGESIA </b></span></font></font></font>
</p>
<table cellpadding="0" cellspacing="0" style="width: 100%;" width="751">
<col width="249"/>
<col width="250"/>
<col width="249"/>
<tr valign="top">
<td height="129" style="border: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-right: 1in; margin-top: 0.44in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Paracetamol
			</b></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">1</span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="1" style="font-size: 8pt"><span style="font-style: normal"><span style="font-weight: normal">st</span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">
			line</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="center" style="orphans: 0; widows: 0; margin-top: 0.54in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">PO</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-right: 0.5in; margin-top: 0.04in; margin-bottom: 0in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">In
			adult patients weighing </span></span></font></font></font><font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>over50
			kg</b></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">:
			</span></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">1
			gram every 4-6 hourly, maximum of 4 grams in 24 hrs.</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-top: 0.04in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">In
			adult patients weighing </span></span></font></font></font><font color="#ff0000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>less
			than50 kg</b></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">:
			</span></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">The
			dose should be reduced to a maximum of 3 grams per day if </span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><u><span style="font-weight: normal">one</span></u></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">
			of the additional risk factors is present (see below) and a
			</span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><u><span style="font-weight: normal">max</span></u></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">imum
			of 2 grams per day if </span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><u><span style="font-weight: normal">two</span></u></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">
			or more risk factors are present.</span></span></font></font></font></p>
</td>
</tr>
<tr valign="top">
<td height="109" style="border: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-right: 0.2in; margin-top: 0.34in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Paracetamol
			</b></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">(for
			infusion) 2</span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="1" style="font-size: 8pt"><span style="font-style: normal"><span style="font-weight: normal">nd</span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">
			line</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="center" style="orphans: 0; widows: 0; margin-top: 0.44in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">IV</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-right: 0.8in; margin-top: 0.11in; margin-bottom: 0in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">In
			adult patient weighing </span></span></font></font></font><font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>over
			50 kg</b></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">:
			</span></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">1
			gram every 4-6 hours, maximum 4 grams in 24 hrs.</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-right: 0.6in; margin-top: 0.04in; margin-bottom: 0in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">In
			adult patient weighing </span></span></font></font></font><font color="#ff0000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>less
			than 50 kg</b></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">:
			</span></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">15mg/kg
			every 4-6 hours, maximum 60mg/kg in 24 hrs.</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Review
			daily and change to oral when appropriate.</span></span></font></font></font></p>
</td>
</tr>
</table>
<p style="line-height: 0.33in; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>
</p>
<table cellpadding="0" cellspacing="0" style="width: 100%;" width="751">
<col width="250"/>
<col width="250"/>
<col width="250"/>
<tr valign="top">
<td height="26" style="border-top: 1px solid #000000; border-bottom: none; border-left: none; border-right: none; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.09in; margin-top: 0.13in">
<font color="#a9a9a9"><font face="Arial Narrow, serif"><font size="2" style="font-size: 10pt"><span style="font-style: normal"><span style="font-weight: normal">Version
			1:2 From: Sep 20 – To: Sep 23</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: none; border-left: none; border-right: none; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.32in; margin-top: 0.13in">
<font color="#a9a9a9"><font face="Arial Narrow, serif"><font size="2" style="font-size: 10pt"><span style="font-style: normal"><span style="font-weight: normal">Author(s):
			Adult Acute Pain Service</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: none; border-left: none; border-right: none; padding: 0in"><p align="right" style="orphans: 0; widows: 0; margin-right: 0.12in; margin-top: 0.13in">
<font color="#a9a9a9"><font face="Arial Narrow, serif"><font size="2" style="font-size: 10pt"><span style="font-style: normal"><span style="font-weight: normal">Page
			1 of 6</span></span></font></font></font></p>
</td>
</tr>
</table>
<p style="line-height: 0.01in; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>
</p>
<p style="line-height: 0.01in; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>
</p>
</body></div><div style="position: relative;"><body dir="ltr" lang="en-US" link="#000080" vlink="#800000"><p style="line-height: 0.02in; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>
</p>
<p align="right" style="line-height: 100%; orphans: 2; widows: 2; margin-right: 0.26in; margin-top: 0.03in; margin-bottom: 0in">
<img align="bottom" border="0" height="59" hspace="12" name="Picture 1" src="data:image/png;base64,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" width="140"/>
</p>
<p align="left" style="line-height: 107%; orphans: 2; widows: 2; margin-left: 0.2in; margin-right: 0.3in; margin-top: 0.04in; margin-bottom: 0.1in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Caution
in patients who may be at increased risk of experiencing toxicity at
therapeutic doses, particularly those with a body weight under 50 kg
and those with risk factors for hepatotoxicity such as:</span></span></font></font></font></p>
<table cellpadding="0" cellspacing="0" style="width: 100%;" width="751">
<col width="375"/>
<col width="375"/>
<tr valign="top">
<td height="107" style="border: none; padding: 0in"><p align="justify" style="orphans: 0; widows: 0; margin-left: 0.23in; margin-right: 0.08in; margin-top: 0.05in">
<font color="#000000"></font><br/>
<font color="#000000"><font face="Symbol, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal"></span></span></font></font></font><br/>
<font color="#000000"><font face="Symbol, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal"></span></span></font></font></font><br/>
<font color="#000000"><font face="Symbol, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal"></span></span></font></font></font></p>
</td>
<td style="border: none; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-right: 0.2in; margin-top: 0.04in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Malnutrition/poor
			oral intake </span></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Chronic
			alcohol dependency </span></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Hepatic
			decompensation i.e. decompensated cirrhosis or acute liver failure
			</span></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Concurrent
			glutathione depleting or potent cytochrome p450 enzyme inducing
			drugs (e.g. Carbamazepine, Isoniazid, Phenytoin, Rifampicin).</span></span></font></font></font></p>
</td>
</tr>
</table>
<p align="left" style="line-height: 0.23in; orphans: 2; widows: 2; margin-left: 0.2in; margin-top: 0.09in; margin-bottom: 0in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">See
the Clinical Guideline:</span></span></font></font></font><font color="#0000ff"><font face="Arial,Italic, serif"><font size="3" style="font-size: 12pt"><i><span style="font-weight: normal">
Paracetamol dosing in adult patients</span></i></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">.</span></span></font></font></font></p>
<p align="left" style="line-height: 0.31in; orphans: 2; widows: 2; margin-left: 0.2in; margin-top: 0.13in; margin-bottom: 0in">
<font color="#0072c6"><font face="Arial,Bold, serif"><font size="4" style="font-size: 16pt"><span style="font-style: normal"><b>NON-STEROIDAL
ANTI-INFLAMMATORY DRUGS (NSAIDs)</b></span></font></font></font></p>
<p align="left" style="line-height: 128%; orphans: 2; widows: 2; margin-left: 0.2in; margin-top: 0.11in; margin-bottom: 0in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">For
patients &lt;70 years old, eGFR: &gt;90 ml/min/1.73m</span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="1" style="font-size: 8pt"><span style="font-style: normal"><span style="font-weight: normal">2</span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">.</span></span></font></font></font></p>
<p align="left" style="line-height: 107%; orphans: 2; widows: 2; margin-left: 0.2in; margin-right: 0.6in; margin-top: 0.13in; margin-bottom: 0in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Avoid
if patient has a history of: ischaemic heart disease, peptic
ulceration, inflammatory bowel disease, renal impairment and aspirin
induced asthma. Caution in hypotension or after haemorrhage.</span></span></font></font></font></p>
<p align="left" style="line-height: 107%; orphans: 2; widows: 2; margin-left: 0.2in; margin-right: 0.3in; margin-top: 0.13in; margin-bottom: 0.16in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Use
lowest effective dose for shortest possible time, ensure stop date
(3-5 day course) and consider a Proton Pump Inhibitor (PPI) for
gastro protection if patient has risk factors (for duration of NSAID
course only).</span></span></font></font></font></p>
<table cellpadding="0" cellspacing="0" style="width: 100%;" width="751">
<col width="187"/>
<col width="188"/>
<col width="188"/>
<col width="187"/>
<tr valign="top">
<td height="45" style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-top: 0.1in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Ibuprofen</b></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-top: 0.1in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">PO</span></span></font></font></font></p>
</td>
<td style="border: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-top: 0.1in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">400
			- 800mg</span></span></font></font></font></p>
</td>
<td style="border: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-top: 0.1in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">6-8
			hourly. Max dose 2.4 gram/24 hrs.</span></span></font></font></font></p>
</td>
</tr>
<tr valign="top">
<td height="46" style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-top: 0.1in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Naproxen</b></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-top: 0.1in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">PO</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-top: 0.1in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">250
			- 500mg</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-top: 0.1in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">12
			hourly.</span></span></font></font></font></p>
</td>
</tr>
<tr valign="top">
<td height="47" style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-top: 0.11in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Diclofenac</b></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-top: 0.1in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">PO</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-top: 0.1in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">50mg</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-top: 0.01in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Specialist
			advice</b></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">.
			6-8 hourly. Maximum 150mg/ 24 hrs.</span></span></font></font></font></p>
</td>
</tr>
<tr valign="top">
<td height="46" style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-top: 0.1in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Diclofenac
			M/R</b></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-top: 0.1in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">PO</span></span></font></font></font></p>
</td>
<td style="border: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-top: 0.1in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">75mg</span></span></font></font></font></p>
</td>
<td style="border: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-top: 0.01in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Specialist
			advice</b></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">.
			12 hourly. Maximum 150mg/ 24 hrs.</span></span></font></font></font></p>
</td>
</tr>
<tr valign="top">
<td height="46" style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-right: 0.7in; margin-top: 0.01in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Diclofenac
			</b></span></font></font></font><br/>
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>suppositories</b></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-top: 0.1in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">PR</span></span></font></font></font></p>
</td>
<td style="border: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-top: 0.1in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">100mg</span></span></font></font></font></p>
</td>
<td style="border: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-top: 0.01in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Specialist
			advice. </b></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">16
			hourly. Maximum 150mg/ 24 hrs.</span></span></font></font></font></p>
</td>
</tr>
<tr valign="top">
<td height="45" style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-top: 0.1in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Diclofenac</b></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-top: 0.1in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">IV</span></span></font></font></font></p>
</td>
<td style="border: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-top: 0.1in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">75mg</span></span></font></font></font></p>
</td>
<td style="border: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-right: 0.8in; margin-top: 0.01in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>IV
			for use in theatre/recovery only. </b></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">12
			hourly. Maximum 150mg/24 hrs.</span></span></font></font></font></p>
</td>
</tr>
</table>
<p style="line-height: 3.05in; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>
</p>
<table cellpadding="0" cellspacing="0" style="width: 100%;" width="751">
<col width="250"/>
<col width="250"/>
<col width="250"/>
<tr valign="top">
<td height="26" style="border-top: 1px solid #000000; border-bottom: none; border-left: none; border-right: none; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.09in; margin-top: 0.13in">
<font color="#a9a9a9"><font face="Arial Narrow, serif"><font size="2" style="font-size: 10pt"><span style="font-style: normal"><span style="font-weight: normal">Version
			1:2 From: Sep 20 – To: Sep 23</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: none; border-left: none; border-right: none; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.32in; margin-top: 0.13in">
<font color="#a9a9a9"><font face="Arial Narrow, serif"><font size="2" style="font-size: 10pt"><span style="font-style: normal"><span style="font-weight: normal">Author(s):
			Adult Acute Pain Service</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: none; border-left: none; border-right: none; padding: 0in"><p align="right" style="orphans: 0; widows: 0; margin-right: 0.12in; margin-top: 0.13in">
<font color="#a9a9a9"><font face="Arial Narrow, serif"><font size="2" style="font-size: 10pt"><span style="font-style: normal"><span style="font-weight: normal">Page
			2 of 6</span></span></font></font></font></p>
</td>
</tr>
</table>
<p style="line-height: 0.01in; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>
</p>
<p style="line-height: 0.01in; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>
</p>
</body></div><div style="position: relative;"><body dir="ltr" lang="en-US" link="#000080" vlink="#800000"><p style="line-height: 0.02in; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>
</p>
<p align="right" style="line-height: 100%; orphans: 2; widows: 2; margin-right: 0.26in; margin-top: 0.03in; margin-bottom: 0in">
<img align="bottom" border="0" height="59" hspace="12" name="Picture 1" src="data:image/png;base64,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" width="140"/>
</p>
<table cellpadding="7" cellspacing="0" style="width: 100%;" width="751">
<col width="737"/>
<tr>
<td style="border: 2.00pt solid #ff0000; padding: 0in" valign="top"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.06in; margin-top: 0.03in; margin-bottom: 0in">
<font color="#ff0000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>GENERAL
			OPIOID INFORMATION</b></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.55in; margin-right: 0.2in; text-indent: -0.25in; margin-top: 0.14in; margin-bottom: 0in">
<font color="#000000"></font><font color="#000000"> <font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Regular
			or high-dose opioids may cause reduced respiratory drive. This is
			a clinical risk for any patient, especially those with
			pre-existing respiratory failure +/- long-term domiciliary oxygen
			therapy.</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.55in; margin-right: 0.4in; text-indent: -0.25in; margin-bottom: 0in">
<font color="#000000"></font><font color="#000000"> <font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">The
			dosage for the elderly should be substantially lower than for
			younger patients, it is generally safer practice to start with
			about 25-50% of the adult dose. Closely monitor for adverse
			effects and/or opioid toxicity.</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.55in; margin-right: 0.2in; text-indent: -0.25in; margin-bottom: 0in">
<font color="#000000"></font><font color="#000000"> <font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">If
			concerned about respiratory depression and/or sedation, please
			increase frequency of observations on the NEWS chart. This allows
			monitoring of symptoms of opioid toxicity and common side effects.</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.55in; text-indent: -0.25in; margin-top: 0.04in; margin-bottom: 0in">
<font color="#000000"></font><font color="#ff0000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>**</b></span></font></font></font><font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>
			When prescribing analgesia for patients with/suspected hip femoral
			fragility fractures</b></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">
			refer to: </span></span></font></font></font><font color="#0000ff"><font face="Arial,Italic, serif"><font size="3" style="font-size: 12pt"><i><span style="font-weight: normal">page
			12, Femoral fragility fracture or suspected femoral fracture
			admission proforma </span></i></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">for
			guidance on analgesia.</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.31in; margin-right: 0.1in; margin-top: 0.04in; margin-bottom: 0in">
<font color="#000000"></font><font color="#000000"> <font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">In
			patients with renal impairment, please refer to the Clinical
			Guideline: </span></span></font></font></font><font color="#0000ff"><font face="Arial,Italic, serif"><font size="3" style="font-size: 12pt"><i><span style="font-weight: normal">Analgesic
			Prescribing </span></i></font></font></font> <font color="#0000ff"><font face="Arial,Italic, serif"><font size="3" style="font-size: 12pt"><i><span style="font-weight: normal">in
			Adults with Renal Impairment.</span></i></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.31in; margin-right: 0.5in; margin-bottom: 0in">
<font color="#000000"></font><font color="#000000"> <font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Pre-emptive
			regular laxatives e.g. Senna, Docusate Sodium and/or Macrogol
			should be </span></span></font></font></font> <font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">prescribed
			if a patient is prescribed weak and/or strong opioids.</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.06in; margin-top: 0.13in; margin-bottom: 0in">
<font color="#ff0000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>National
			Patient Safety Agency (2008). Reducing dosing errors with opioid
			medicines.</b></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.06in; margin-top: 0.13in; margin-bottom: 0in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">When
			prescribing, dispensing or administering strong opioids the
			healthcare practitioner should:</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.31in; margin-right: 0.5in; margin-top: 0.14in; margin-bottom: 0in">
<font color="#000000"></font><font color="#000000"> <font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Confirm
			any recent opioid dose, formulation, frequency of administration
			and any other </span></span></font></font></font> <font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">analgesic
			medicines prescribed for the patient.</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.31in; margin-bottom: 0in">
<font color="#000000"></font><font color="#000000"> <font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Check
			starting dose, frequency of administration, standard dosing
			increments.</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.31in; margin-bottom: 0in">
<font color="#000000"></font><font color="#000000"> <font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Ensure
			where a dose increase is intended, that the calculated dose is
			safe for the patient.</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.56in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Titrate
			the dose to achieve pain relief, increasing the dose by no more
			than 30-50% of the previous dose every 24-48 hours as  needed to
			get pain under control (</span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><u><span style="font-weight: normal">N.B</span></u></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">.
			this excludes end of life patients).</span></span></font></font></font></p>
</td>
</tr>
<tr></tr>
</table>
<p align="left" style="line-height: 0.31in; orphans: 2; widows: 2; margin-left: 0.2in; margin-top: 0.11in; margin-bottom: 0.15in">
<font color="#0071c5"><font face="Arial,Bold, serif"><font size="4" style="font-size: 16pt"><span style="font-style: normal"><b>WEAK
OPIOIDS </b></span></font></font></font>
</p>
<table cellpadding="0" cellspacing="0" style="width: 100%;" width="751">
<col width="187"/>
<col width="188"/>
<col width="188"/>
<col width="187"/>
<tr valign="top">
<td height="165" style="border: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-top: 0.74in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Codeine
			Phosphate</b></span></font></font></font></p>
</td>
<td style="border: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.1in; margin-top: 0.74in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">PO</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="center" style="orphans: 0; widows: 0; margin-top: 0.74in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">15-60mg</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1.00pt solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.1in; margin-bottom: 0in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">4-6
			hourly. Maximum 240 mg / 24 hrs.</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.1in; margin-right: 0.5in; margin-top: 0.04in; margin-bottom: 0in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Not
			 to be used with PCA or Fentanyl Epidural</span></span></font></font></font><font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>.</b></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.1in; margin-bottom: 0in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><u><span style="font-weight: normal">N.B</span></u></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">.
			A percentage of patients are unable to </span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><u><span style="font-weight: normal">met</span></u></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">abolise
			Codeine therefore it may be ineffective.</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.1in; margin-right: 0.4in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><u><span style="font-weight: normal">N.B</span></u></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">.
			Not to be co-prescribed with other </span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><u><span style="font-weight: normal">wea</span></u></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">k
			opioid (Tramadol) for acute pain management.</span></span></font></font></font></p>
</td>
</tr>
<tr valign="top">
<td height="221" style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.1in; margin-top: 0.59in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Tramadol
			</b></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">NB.
			Please refer to </span></span></font></font></font><font color="#0000ff"><font face="Arial,Italic, serif"><font size="3" style="font-size: 12pt"><i><span style="font-weight: normal">Summary
			Product Characteristics (SPC) </span></i></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">regarding
			contraindications and drug interactions before </span></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">prescribing.</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-top: 1.03in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">PO/IV</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.1in; margin-top: 1.03in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">50-100mg</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1.00pt solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.1in; margin-bottom: 0in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">4-6
			hourly. Maximum 400 mg / 24 hrs.</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.1in; margin-right: 0.3in; margin-bottom: 0in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Avoid
			in the elderly and/or patients with dementia.</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.1in; margin-bottom: 0in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Can
			be used with PCA or Epidural Fentanyl. Trial start 50 mg, if
			tolerated may increase to 100 mg.</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.1in; margin-right: 0.4in; margin-bottom: 0in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">If
			administered IV ensure slow IV </span></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">infusion.
			Please note, adverse reaction may be dose related.</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.1in; margin-right: 0.4in; margin-top: 0.04in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><u><span style="font-weight: normal">NB</span></u></span></font></font></font><font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><u><b>.</b></u></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">
			Not to be co-prescribed with other </span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><u><span style="font-weight: normal">wea</span></u></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">k
			opioid (Codeine) for acute pain management.</span></span></font></font></font></p>
</td>
</tr>
</table>
<p style="line-height: 0.09in; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>
</p>
<table cellpadding="0" cellspacing="0" style="width: 100%;" width="751">
<col width="250"/>
<col width="250"/>
<col width="250"/>
<tr valign="top">
<td height="26" style="border-top: 1px solid #000000; border-bottom: none; border-left: none; border-right: none; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.09in; margin-top: 0.13in">
<font color="#a9a9a9"><font face="Arial Narrow, serif"><font size="2" style="font-size: 10pt"><span style="font-style: normal"><span style="font-weight: normal">Version
			1:2 From: Sep 20 – To: Sep 23</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: none; border-left: none; border-right: none; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.32in; margin-top: 0.13in">
<font color="#a9a9a9"><font face="Arial Narrow, serif"><font size="2" style="font-size: 10pt"><span style="font-style: normal"><span style="font-weight: normal">Author(s):
			Adult Acute Pain Service</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: none; border-left: none; border-right: none; padding: 0in"><p align="right" style="orphans: 0; widows: 0; margin-right: 0.12in; margin-top: 0.13in">
<font color="#a9a9a9"><font face="Arial Narrow, serif"><font size="2" style="font-size: 10pt"><span style="font-style: normal"><span style="font-weight: normal">Page
			3 of 6</span></span></font></font></font></p>
</td>
</tr>
</table>
<p style="line-height: 0.01in; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>
</p>
<p style="line-height: 0.01in; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>
</p>
</body></div><div style="position: relative;"><body dir="ltr" lang="en-US" link="#000080" vlink="#800000"><p style="line-height: 0.02in; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>
</p>
<p align="right" style="line-height: 100%; orphans: 2; widows: 2; margin-right: 0.26in; margin-top: 0.03in; margin-bottom: 0.07in">
<img align="bottom" border="0" height="59" hspace="12" name="Picture 1" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAUEAAACGCAYAAABDlDiJAAAACXBIWXMAAA7EAAAOxAGVKw4bAAA3rklEQVR4nO1dB5gVRda9jGDOWUy4hjX8rq677pqXNa5Z17wriDDhvRmCGNas6JoxZ10DKIKOMszMm0xOAgoKCIIECUqWnGP/91RXTdfrVz0RhMF7vq++gX6Vurrq9E1VTSQQCAQCgUAgEAgEAoFAIBAIBAKBQCAQCAQCgUAgEAgEAoFAIBAIBAKBQCAQCAQCgUAgEAgEAoFAIBAIBPVC806NqdUnx1JG7qnUOu8USbVMWZziRb/b2o9RIBDUFS3yDqR4ooJyyhZRdomkWqfSxfz3MyIvbWs/SoFAUBekdz+IYokveTF7FC92p1hR9SmqbE3qiRfVrK1q26iqbFXldZ6sBCf7r/53pnUtXJcat5KEkKBA0FBRSYIlenEnp7TsIm/fO8u8A+4qj0x73VHmLGunxtnF3n53OsrfXeHt1qG0sq29O5apa+F8+3NqnFNskVA4Jbzd2pdG9LHC27V9aWqZWMJrlFnoNeY6D7+vj3fus0O8m94e6aV/NMaLdx/rxTi16TpaXbv4xWHeiY/29/bqWOqlMSE2AimiDjVuQoICQcNFVSTI5HDUg/28H+au8OYtW+PNXZqa5i1b6w2dusg78r7e0STIZHPWc0P8ekLlFyxf693eZbSStH53fx9v8JRFqs5wOyOnL/GOfbifqsvVxs5Msi/3/TGlfqSZi1Z7t7z3jdcoFtzXDvz3z08O9B5NTPK+5P4vWrnO27hpk1cVVq3dyHWt8grHzPUue+0rvy9CggJBA0dVJJiZ8C57dbi3cWPV5AACufy1EZEERRmFXka3sd7a9RtTyq7fsMlr/vyX3Fahd97zQ705S9Y42xg4aaF3CEuIUUS7L0uTgyYvdJZduGKt97fOQ7RqnFD13Jc3wZv2y0pv3Yaq782FDUyWOT2+U/clJCgQNHRURYIsnd3b8/vqSYFJ8rmKKV6TSBIs8F7t96Oz7AyWrJqyKgoSzPxkrLdq3YaUPBDQ3hk0w9slpzhC0izyjn6on5LSXJg8b4V32H96KwI8mNXjorHzmPxSCbmmQDsnPz5QJEGBYLtAFSS4W9sS77ORs2tEDMN+XOzt3cFld4M9sMjr/8MvznK9JyzwdmVyS2Op6p3BMzyXXAY1NYslyUZRJMsEeilLomsjiA2ktyOry+gf2thQjWRbHfK+nePtbWyMQoICQQNHFAkyeR3B0tOoGUtqRAxLV6/3Tv3vQN+LGrIHHszqJ+xyLnJ7rf90rwmXacxp8ORFzrohtTXvPDS1bktt7/jZuMi+dS6f6lGbAu/y10d4S1ati8y3llXjMT8t8xJMmp98Ncv7eMTPTHhzvWFTF3tzl61REul67ku7T7/z0mLiGBEItg9UQYJnPzfEm7UklbyicGfu+MBrapFg8+eHesvXrk/Jv2LNeq/Fh996jZjEmjLhLljmtgfOWbrGOxD2wAhJsAlLeSAtJ7Gt3+jd/N4oLy29wOs2/OfIvkNSPfuZId5OkEq5nTTuU1pGQnmCG3Mbe3Us8y59ebj3RMlk77iH+gZ9ERIUCBo4okiQSeD2rqO9lWtTbXRRyB89x9ujXageJpGMj8Z4axyqKsjt7GeHeMRkcxYTUJR3duiURcqbG+UUOeiucu/r6W6JddaSNd6fnxrk7X9HqfftzKXOPCDKa978ynd0uEJwtEMF97Jjth/KU/mbkKBA0MARRYJtCr03BkxnFTCVmNYwabj4asr8ld4pjw0Mha4UKZXXRXDjZi3zPb5MLtndv3MSFPAm90MRVAQJnv7EoEinyIhpi73DuI2j7+/jzVrslmpXr9vgXfDiMGVbjAzziUpCggJBA4eLBFnygRo40BFyAi7LHz3XqSavYKmxzcdjlBRp6tqPJbCK7xc4ySd35GzlsNiZVdD3hsx05lmzbqOX1e07j9ILfWksnLitG94dqWySKX3l1P2rn709uf5jH+jrzY4Iv0G+xJi53imdBqjA6chQHyFBgWA7hIsEmQCx0wJBy2GsAil9MtYrYNJwoduInwOpTYeu/DB3uTPvQwUTVd6md5d7g6dExfitU2o5COqUxwempkcHeG8MnO6td3h84QW+v9cERehQmcfNdvfD5J0wZ7l3zxffeyc80k/tJIl0xAgJCgTbESJI8NznhjpVWNjxznt6sNf+s3FKLQ5j5sLVauubsaFd9PJwb8WaVLsiyl71hm+Hg1d52oKVTnJCF5AX8YNRyUWAALy9l74yQvUDDpvXWS2vLjgGdWEXS4+vZnnXvvk1S7Jl0aE5QoICwXYABwli0ed0/85p9/uepanjHujjnfnMYO8nhx0OEtXfX/hSHzxQ6LX7dJyznp8Xr/ZOYCkOJHjt2yO9ZQ51tr5Anc3u71NJyKczeWPrXk2BnTBw9pz17JBox4yQoEDQwOEgwV3bFnsffPmTkxhKxs3z9mxf6u3LElL5eLet76nSKV4TTab/i7D1DZq00DugY7kiwceKJjmJsr4YOWOJt6N16EIa/z2381BWi5d5tYmXhlkAjpuU8B8hQYFgO4CDBA+9u0IdiuACtsepODpOD/Sa6MwzYNIv3iF3lqsdGkMctj4QHshx1+xiRSzYgbEl0HXYTyleZRDzyZ36ey/2/pEl2dXO/cwuLF65XnmQG4VDaIQEBYIGjjAJMin98YmB3oxf3CEnLT/41vf+cr6znxvq3OuLk1vOZBXyxIf6eTMWptYDG19Oj3EqIHlvlii/n+N2WKDuivHzlec2MWZeSsJ2OJdKDuBghLu/+N4dWqNJ/NTHB3oPFkz0vp62pEZ7iYu+m+ftf2eZkKBAsF0hTIKZhd4t73/jrV6XSgrL1mzwTn9yUGUIDBwgIx3b6qBq3ttzgnf5K8O9xY5taktXrVe7SFDPn5iIlqxy2wOxZW9/JsldoaJnp6ZDuX3sPXZhwYq1yilTpYcX+5qZDOH8uOaNr1Xoj+u+DWDHhH0wKYRGSFAgaOAIkyBLTk+WTHZ6UeFUOOieikob244xBEJPc3qRIaXd9fn3Tg/ydJYOj8D5g0xQN707KpJ4Pv16trdTlGeWrx//cD9vfETYy4S5y70THulfs1i/mL9DZt/2pd5r/aY5+wwgDvKm/41KDqoWEhQIGjhCJIh9smXj5jlJAAcL7JaT7EVGmMvilanS3i/L16qDUF0EWc4qLk6W2ZHreLZiqvNUF9jq7s6bEBxU4CDBS14doTy4LpSOm6+cN7Xa/cF1Hn1vhTfmJ/f2OpBjSxwAKyQoEGxHsEmQSaApS3qT5qXG7IGoOjNhJZ0ZiJOn7+/jtOmpE1ciXLDP956qJM59WPIqjAi6RpD0FW98Fb17g4nors/Hq0NZnW1wXxvbkl4NibAZ33/UyTnYlXLNWyOFBAWC7Qo2CbJ6es4zg502uuXmxJcQKYFoukaE07gACe82rgckiBi+8bOXOfP9uGCld1JV6mx6gfdxFafCtHzfd+DszkR77EP9vB1iPnEqG2GYWPX2O3UC9kdjnJKt6ROcRkmkKiQoEDRwWCSIODpsiVvjsNFhp8gZTw1KlaqYPFp88G2kRBYGnAunox4mpHM6D40832/ADwu9faLU2RhiGUucThlg1doN3mk425DbQFgLDmro8fUsL7PbGO+s54Z6xzzY1zucJb6md5WrwxXw/wteGuY9Wz4lkgCBvNFzWMUOHRwrJCgQNHBYJLhTdpE+OSaVALBT5HB1RH0qIZ3Qqb83PSKkJgwQ15Goh6UunBYd9f2StwdOV6TsJEH9USaozC5M477sc2e5l8Yk+Ejih0q1HGEwCN+BM+WraYvVEV04ZQb//2XF2ioDqGHbvPrNr1MDpoUEBYIGDosE9+9YpnZyuJD3zRy1C8RFSnu2K/E+HzWn2n25AA5Y2K1tsTpI9S0mOhdAwjEmyMijrZiI8GGnKC9u4Zh56ty/XbidYT+6g75rA8QrPlc+1dtBdowIBNshDAnGi71jHnYHNwNPlUxOOiLLTpDY2n82vtrdF5t0/CCkqT3alyqV1wUcuHDOc9HH6e8QT3j35k1wepUhsT1TNsXbIaPAO6nTQGXLrCvQX9hHny6brF4QTgeLkKBA0MBhSDCrWIW7uKQrkMHN746KJEG1y+Txgd7iiKBnu56LXvIPLz2+CsKdOHe5d4Q6+MAteeL06k9HznKq7fDgqm8MMwnCVllV8HNVAPkVfzfPu4IlzibZRdFeaiFBgaCBo5IEi7zr3xnp9Zu4QO3CsBN2Uvy+U/9oIoCjgonp7UEzvD4TUssj4TpI5ZD/+CdJn/bkIC//27nOfPgwUsox/Vbaj6UyHIvlauvzUbN9r3LM/y5I8xeGeXfljve6DvvZG/7jYm/y/BXqyH0clwWbImyBsBMigBu2wV6j53iPFk5UO0P2UcdoVRNWIyQoEDRwWDbBnduWqE9J7hVKe7Yv8dKyI775a6Xd2rnLI+2t62mk8zbJKY7Mh099NqqiHXzjY4+Itvy+JkupkDxhzzzwznL1kaQznh6ivMGXvjpCba07r/NQ75THBiiHDbzOZm90jWILhQQFggYOkGA8MYxyyvwFvb2nuEnFoVTH+tS4FRcJCQoEDRW35x5AseJ8yi6ayRKhpNqm7GL+W9JFSFAgaLDgxZvZfX9q3aOppDqmG3L33dpPUSAQCAQCgUAgEAgEAoFAIBAIBAKBQCAQCAQCgUAgEAi2AezI6SJOV+i/u23d7tQLe3K6hPx7OZ9T463bne0SiL0zY/w3Tls6GPk4Tq9y+h+nxznttIXbE2xFnMApi1Oc09WcdnHkacTpr5xiOh9Ia4d6tnsgp2mclnGawunoeta3NXEKp5nk38v3nPbYin35O/nPCOnciDwglFt0ntacDv11ulYvnMNpFvljPIr8l+iWRHNOizh55D/ThvySFlQDEOA68h/2QE4HOfLgrfscp006X0+q/yREO/N1fXM4HVvP+rYmTqNgwcwgXzK0sTOn/+PUUv/dkuiq+4H0VkSekzlN1nkWcrpwC/dpcwDS31Ly+zyRUiUzvLzxMmrF6fjN1N5C3d53JCS4XaMNp7XkP+z+5EtoYYAEn+K0UefrQfUnQRDFm5w+5vQ6p4PrWd/WRDNOb5N/Ly9TsjS9K6dHyScdLOJrtnBf3qeABF+PyHMSpx90nl/Ilx63dYDYoJpijPFCtk0OmEvPcPqR0xLy1eb6QkjwN4StRYK/FezDqZj8cdvA6aot3N72SoJVAXMWcxf3A63m4s1Qp5Dgbwj1JcEm5NsIsbibkz9ZYGdsS/4b+3H9216hOqHOXKJ/u1iXQzvn62tXcvqdoy9o90Kd51JKtr9BAoPt8g5OnTk9ySmdfFW7Sage2MX+oev5P132Ql2mje5fIz0e6MvDnJ7n9ASnHE5/surcy6rrAvKllF31uNzI6Ws9bhv1eFyu8x2uy12pr+3nuF9IyJfpus9z3EcYm4sEocL/gVMG+VIWxhPP9Exy2zwxVgfo+3iI/LHCWGKs/kLBfNmbgrE6W7dzBqf7dBsP6PsMt4Hndakuh/5iruym64J9cywFL5oHdT/O1/UDeB6QJm8K9S9Tj0f4pV4VCWJunKzvzYzN/Zxu0GMgaGCoLwlick7TdcBg3Z7TeCsvEtTAFyl5IqGdn3U52NGO0e3k62tIr5C/uGxgYS7Rv4/mdIi+DiJ6hNPsUNtYFFggrUL1nKPzop4XyF8Mc3SZCl3fiZx6cVph1YcE22iC0/66rlM5zdV1Qe2FetaM03R9ze7POisfSHKc/v8qTrc57vdO/RvydKdfhwRBQCD7qeSPn6lvo77Pd/T92fg9p885LafUsSqnYF79hYKxwny7i9NPoTLzOL1EyXY/OHkW6HJj9W9HW9dcY4yxNfPj3+TbEtdSclsoN4l8p5+NKBLECw5zfEqoTU/XfQUJGhw2BwnO1NexWFeTPzGHkj9ZTZn15C9yAzhG5urf4PUzjpEWFCwkTNojrDIgiAes+p7R/UD/XrDuA6RcwKnEagNEfBUFoRUgQeOYGaj7sEnXW0a+GtubAmcQiBoE3VPfG5wOu+u6/kg+mSAf7FIgwcM49dFjYAz6m/Tv3+o2mpFvF92kE+re27pfEJ5R80DE/6TqYZMg7GeQyk8MpSv0GLlIENJoF+u+4Y39St/zAus+BlJAhIgUKLbKgNQw/l9wGsLpAwo0gb9YY4W615D/8kG+CRSQLv7eS8E8g3S4WP+GlyxI8AjdL5CUmTPoAwgKY1xIgWR2j24LZYs4fcZpGKeVuhxerGdY4+AiQcy/K3VeM99Rx6ecSsknXbsOQQPB5iRBpOnkq4B4A0M66EfB4vjIKhdFgojPGkMBcV1HgXQEyatC/4YFeYG+jnbMhMVEbE7+ottX92UlpZKMTYIgbizMN8hXceDFhSpuFhYI6BZdJ6SkpuQvQEOoLhJsovPAY9mXgoUN9fwo/Rukiit1+/gdi9f2HoOwjNcZKnUzqh42CYI0fnAkI7m7SBDzYRkFElmG7iueJ0KovqNA2nqa/Od5IAUEBWJoZY0Vyh1JQUiVTYJIE/QYQO2HRA3J28yzUXqsABcJNtFjAtPElxS8HG/V5Q632oVD6j/kzy/Mgd3179BQNugETcI4XFwkiDY7U0DUIP6jdV14aR5LYjtskNjcJPiIVa6Rrt+8bSE97KN/iyJBTOzOFKgqWNTG23qezmv6urvu2x06LxZmW0oNpC3XZdDPk/Q1mwSxcB6lZLsQSNCQExb23brPYXUVcJGgQdgxcnWoLBbkeKsf2fo67qG9voZ7e4yqV4UBmwRrkmwSBGEMoECietpxvzfpPiEPVHrEGOKlYEwGkLYgrR/sKAvYJIg2bg/l+zMFxA8yvlxfd5GgQU0cI2ZONNJl99AJavZq3ZduFEj3LhKEfREB1GYdQHo9i8RJ2OBhk+AAiiZBLIjqSBD1XBAqC9XLTOrBFBj/o0gQMBMTv8Fec7i+DqLCAgSZ3KWvweD9HgWqLFTWl6yEN70hGfTvH7qcTYJQb/4U6jcm/DAKpFhIhd+Q7+xpTsmLsD4kiEUJ0jdjC0kIY4txLbTaDvcvCjYJov8w2D8YShgXo9raJIhnb+yiICBX/CCexc8UEJ5x1gy07gH9hb0WzgfMh52t8jYJgjjDzq/ddVnzEszR12tDgq4QGTwHOJheI99MMlSPD9RmPBc851wKnp2LBLEOoBEY8wbKYe7mkW9ThgnERfyCbRxQzwwJYmI0deTBw0f8myEE2EBcJIhJ88dQWUxIM+lrSoJ4Qw+nQDqCSouFZlQe2OdOsfJ+TjWTetD/lrqcTYJY1K44RXgX8ba3nQPmPjtQIKHWhwSBv1tjAXva8RTsQjEvp5pIgYBNgq9G5IGa7XKMQLVbbl3/i6Msnt8kq40r9XW8uGD6WE/JY4UXINTQXXU+mwTx3MNH0YNEBlnl79HX60OCIFa8KA15bdR9+IkCWzAS7IRVkSCA+fYsBXPHpPW63yc6xkywjQOkgDc6HiQcEa5oe6hJBRQ88K4U2FpsEsTE+EOobF1IEKSLhWPIuQun0ymw7cG2aEIodqNglwQmIpwBCIF4OCKdqsvZJDiRUhcjgAUJ2xZUMjheYG800g4kpuY6X31JELbOEp0HEjDscHfoe8X/sx1lolAf7/BhlCylXeYoC8nNPDeMt5H8MVZ4JghjgWRrO8VQp5Eqw44R2/EFgCxtSbCtvl5XEsRcwq4ozCWMJ5w8UOmbkf9soM6u0mXhyDEOnCgSBPBCgm0R5gpI7rbjqwslS76CBgCEaRh7Dv7COxsW6TFRjQqE9LT125YgQeB0q14sWHhRQSIg7JutPsKQDTskJiAWQEfyCbpRKKVR8n5nmwSxN9T2yroAyRfb42ZQQGhZ+rfqSLDEKuPy8KJvHShYSFhYxgGEez+5mr7ZqA8JglhGWf14nJLtqxjH6yiQjPHcXHu+QRKQZM3WvI36/gCbBHH9Gkqeb5g/RlWHVGqCy6sjwQEUkOCl1m8g5m7Wb/+iZPvgPynYNopxN/OgKhK0xwPPF1EK5oU9khrGXmyBBZAYJByzcOChhLQCrx4IC8GxedbveHtfECq/JUgQquanFCwWM8kmUWpQMYzpRo0DCUFyM29jTHioulhMkGwMEVZHgih3im7LEOlRenw83Z9WOm9VJAjJwoyfcTbsrpNtUEfdZtGhbrMw4bGuzQkm9Y0TRFiK0QxA+JgLu+m+YsyMmQJECBUT42zGCuEoZqzw4hxv5TUvjLB3GCaY03X9R5Iv5RsJEtLkMbpcVSSIZ2ScX2jrId1nECDmpzGXQHKF+aeJ7iNeLpAgjZkHoTPGcRdFgjAXHUvBs8PfB60xg8nGtf9esI0Dp4kY5wUmBCYpnAAwHEMCNHYeLEw75gvYUiQI3ErJNib07TVHPkiD2LtrVB7UB9UGhvl3yQ8vQd/sEIjqSBCLGwsedp43dLtQpYwUhIVhJLSqSBAL7kHrPrCwEFOGYOtTrXxYTHkULMgo+1Z1qC8JHqH7tlH3Za7uLxxOIEXjRBit7xtkgjHFOJn4SQS5D7PueSIFtmKbBI1kD4kRUtjXFJAJymLcDNlVRYIYu6cpeDZ4rpC+YcKBeQdSqHmp4B4wh/E8x+o6jRMO0rcJgHeRIO61lS4HYsX86mblQ58hPdf3hCXBVgCkEhAhyMxehHaCBxUb2A8JlQWpmbAVTIZTQr9fSsEkwcIwkwzSmVF7YF87ztEvSAbfW33A4okiBUghz1MQyBpOK/Q9mgl6HgWLEYSwT6i+PSnwlNoJ44NxupYCZwU8t+YlMpNST5EBsXxFyWMLwj7fyoMFhnARe8cFPJfh7YbVoYtV/s2IPIhFNM4NPJuwRx8qLha5sZXZCUQD6ekcKz+k9pmOvEh4icKxZSQnmwRRBrtgVobKgJQQgWC/mJpT1afI4CVqts7ZzxzbKDFHESMa3i2CHUNwvPxIwUvaOMjwYjCkizmINYK5c7ejHtNn3IvLsShoIMDbHCoZpC+QSRfy33KQJmCkh9TiOmsQkxFbkhAiACdLWFWFsf02/ftVFExe1NVCX0ebrsVuDl7N1On6iHx2X0BI2Gr2ru4/iBsTHaRnG6wP1v1FvTdS6qJqrPv7EAWnl4BUoE6ZLX4G+1v3CJuTy5MLIoSRvwv5Kh8klyNDeVCvMU1AcnmUai9VNKdgvM6OyAPCh101Q/fbtXCx6CENPWL1GXttr9LlbTse+ohQKEhuGHeM1Vu6D8eG7sEmQWzL21/X+Zouh/AdmC3CLxK8fFtR8LzC44L+wGmDudpVJ2z9M/Y5ECpU+9f1b53It/Fijl2v64V90qi9h1DwTPF7Y90GXhBQ7V/QY4KxQQznRRTEGAq2A+BhN9GpoYr2mLRNaPOc8mzq2hxjYcbVdTIyXiBQKY2JIIrEfk3Yc6EmMXDVjVWYBA1x7EDR41JbVDXGpp36xvOlUe3GRSAQRAASCqRESMyQYowKBtVqewy1iCJBgUDwGwVMCbBlQQ02Ni/s2T2/qkINGEKCAoGgElCpsM/W3pECRwJsTtvrflSEw5ijtOCQEhIUCBoAYPfZWafNbSOF4wDGdxwqCvL7A9V8i1xNABud6fu28BU8xO4h9hTb7ECIDdXmLBBsVsBTjEWB0z/gkdyaX2sLA4SE0BV4PeElbkhH0UPShEcUh6AisPm6rdsdgaBhw5x9d58jIQQF4SYIOXCF0VSHZuRvZjeHjp5aZe5fF5CgEAph1NV2W7c7tQKkLPv0n+eqyY9QGewYwTOFk+ZwR55m5O/rNs8e2xRdMZ5w+LTXeXASjOyiEDR4II4OcXcbHQk2LQS8TiM/xjAcUF0dEJ9oArXrQ4Kwo2EhI+4MjoXNEW4RJsGcqrNvUwAJIrbPkOAz1eSHh3o+BdsUWzjyIHZuAwXPHkHCHR35INkv0XlqeiBsfYHnj7mHQPaLfoX2BL8xGBI0ZABPJrYgIere3lmAIF8EvtbG/oSAWUgp2PKFE0hcEkhN0Ir8vb1YwE/Vsg9R+C2RIOLd+lBwr6+Efsd4vkSpuyU+DuUzB0KYrWrYpvZrnLiM4G/sJsH9dv4V2hP8xmCTICYZdk9ghwP2ZiLCH3s17e9xVCcN2kGrSCCbXXRySXAmaHdHchvT8fvTFOzhRBR/dSSYpuurKuB1c5DgDjVop7qyNXEg2IHNpmxtSBDAuBlvNQ5KtXduIJjbfCoAe3wNyY2lZGcOPL4YMzMfWlPqfZs9x7W9t6ryv0DBc3o6Io8NM7ZmN0htIcHSvzGESRCLy56MUH/MkVzY/2qOscckw5a1q3Ue/B8HT2IPJsJDcAwSzpAzn9GEGhPeGgeyhc0R0h0kRtiZsHUK6htI6mxdNpeC/a2f6DaRwlv5dtR96aDrw/YqbN1zHQtVVxJM0/3GZxjv1+1gzFqR+8zGA/Q9oL84bAAvA3y0515dFuOF03KiFlwz8k8Jf1q3gy1g2N6GDf21IUF7rzdMFCdYv9mHseLIqG/1v2EKsbcA4gU4goI90uFDNdAvjMuj+t5gY7Q/j2nDnN4DNfwJnR/b827UbYLA8Pyxba8XBc8pV1/D/YRPS8fYNid/TFEfiB/P33UyNJ4jngeey2W6Lsyn63V/MN4wG4jN8zeA6kgQXlNDgnBymD2bmDQ4PABSAxYGnCuwHYKoppNPlkfpfyMP1Flz4gjaRNiIOcnGtkGu0L9hwfXTZcOf2lynkwk8xgQHkeCUlJWUbNtC/diqBtKwD1itKwmCtBfq9sPtIE6uLSXvV76Igk9F4sQWSNpLrbIbdH0oZ8cQmiPfp4bGCPVAkutBgWRXExLEszDkhmPTrrd+wxFl5qAIfLbgJQrG/ForHw4tMAHRY6z7RF/xshtJwfMy9wbbIk59AekaIkI5qLjh52++J4OXGNTsIZT6/E0eHNJhTr9GvYg+KNfthZ8LNBi8sOyXMJ5/N10Xxh8H8w4P9R9lcYTWH0ikwu0aYRKE3Q8LBnFueOPClgT1B4sPm+fNQoWE8xUFp38Mo2CRYuGCBJtRcFgpHCPmJBrsLphttYnFidNAMIlxvBEW6P66XziOyT4ODBN2kr7+V10f2hpOwXHq2KIGYjbf/jWngeDtbmxYdSXBO3WduB98XjNPt2VUyDlWv4ALrb7DobBK3zvKmCPHkPACsY9wP94aO0/f09c6H9oyp3HXlARx359Q8CLBS8GYFe7VdaI+SE44TMIcfYWDFsxLERKpIaQuVt04vcacGo1xHqXHZaxuC2SC02tMADUk4akUmDjwzPH8cbQXni3IH1Jdd/1/s+UQCXPhB91Gc10fjj4zNkMkOIFG6LLmPpbpezFSKf6ak8vNiwgvYBznBYJfaf32DtUtOkLQQBB2jGAiYCFjUpiz56A+QUU4wCpnkyAmMogB0gnsRFgsUCOakZsE77Xaw8I2am0jXS/sVWn6L6Q3Y7THhHxW58F1EzD8MQWLE+ff4Wh12HQQzgFyM9ILFtANuq26kiBeDDgWvykF0gEIBt9qMUT4uJXfkKBJONvuJN0/SMb2B8rNAaX47RnrOsYfH5Iy3+Q13zQ2v9eEBIG4VQa2XkNKxtwA8oAHHyRuiAcfhcJY43m8S8EcaaXLYhxx5qOR/CBRmXhQnOjzBQWfvrxCj9l/rLHCy9OcdmOe/x7633j+ULHfsPr9sr6GPu2o/20OV0Uf8E3pP+oxxIsUoU/2N4hNPKhNgkh4OeEFt7duH5KjGWNoMYfVYHwFDRRhEgSZwfaHiW5UPrx1ob7Y6qRNgkgDKDitOU3/bUZuEnzAKgeJ7hxdd10cI5BYzSGqmOyXULLqgvt7mwJpLJcCh01dSHAn3T4kAyzAA3W61upHF6uPNgliTO3PRiKPPfb/1dfxAjEfJcI9P0vJKjYW5BSrXE1J8DQKTBtmYeM+zDFfkKab6vuZSIFzBDZQEIr5INZ08s0PAIjOnA2JMofrviJhjGHDNJI8HBwgJxDMOqsMTAZRz58o2TESvlfMHXPuJca/OSU/f7ygQMSG0EyEQ5gEQZ62jRnzyrw8QZ72d6MF2xnC6jDsVjg7D7avTuTbeYyag90JRp20SRDECWN02PvbjNwkCCIwHwJHgloIVbg9pcadhUnQVuMALDIzwaFW7U+pCH9T12w3qwsJmoUN6QTq2yCdoNIb1QtqnDEb2CQIQrG961j0L1q/G88nVGFDLEt1ezZ21G3UlgT3osAuiL42J/+sPkhB5vu8kILwHI0z4hedDwRqvkcDm6QZZ0hd5sDYGXpcXrUS+mmIF8fcQ9LCi2qe1X/Y9/DRKswhl8Rlj1H4XjMpGHeQePi8QsyfGAWnTA/SfbdJEHMDmo7tCcf8Nt9Swf2FDxUWbEdwOUZMaAEWKXYNjKFAHTXqpE2CUJ1cX1trRm4ShPQB0plAweREgnQAIsOJyPZHc6oiwdut8rADuQ5nhffPxDzO13nqQoIgsC66LowFCAp2p7H6r5FuokgQC9CWNnCPz1q/GxKEjcssQJglwifPmLi+2niHSfcJ9i3z0sA3nq+hZIeEGfcHKfjmM3aZ4LBWQ3a28+wcChw0myhQfe1kzCogKYwhxh6qP6RA+/mjLZB/+CPrVZHgA9Y4QJoLH6KL+fMvq++wXR5KySSIPuRQ8kt8XwqkYSHB7RxhEkS4iq2W7ELJKpv53SZBvMldkfzNyE2CABYyFjve5LA7mePzN+n/G7tSdSR4s9W37ynZbmmAY63MQoV9DdJsbUkQ/YCkasj0W9027HuQpvB1M+PowHduzWK0SXAAJZsUokgwLAleScmAxNKFookhCmgPNlsjmcGWCvPCJkpV1dGmkdbfp2Cb3kZK/rIenFyGyKbqvjzhSCBO2FKNpIZnCEcQpDSoq/bnB0BmtiOiKhK0g7dhXw5/TgH3jOdmS4swN4RJMIuEBH+zCJMgJqxNgrD5DKZgEprPNdokCOkq/D0LoBlFk6ANLIjWVhvTKNhdYpMgiCy8YwS2GnNeHyZzWIoAYRiDPlIx1c0miHsuokBiDUu+rShYyDDU14cEwzZB3LMdPgN1zv5GS01JEID6ar4bArugeYa4ZquivydfUvf032/0v2F/s78pDKlqqlVfXRwIRmU1Dgy8TJpZv9sk+HyoLOadscVCdT839DvGDaq9kX5B6Ob0ICFBgUKYBHGiChYKbEAw9iOswoSZYEEa+1R9SBBlIe1AKsBkhJeyDQUTHYvOtp11sn4DEWHh7aPLQqrLp0AlqtDtoG6onpACTTgOJJt0XWdtSRAvBvOd4fW6v2gbEgtMBiZEx9P9MZJMXUiwSeg6SAbju5cel0cp+Wt9tSHBfSj4li9eKubZ9qFUm5j53CXaMtIWrtlnBeI+QSZGSsSWvGb6+s66z5D4c6x7R90gWfP8MY7QCIyECkK2v48CKdKMLcKS4LiBbRHB+HhJl1Iwfwusus03YszLCSRrvncsJCioRNg7DHUPb1Sop/ZCw4IBCRibW31IEKrWdPInLD6Qg+8Qmy/AoR1IbrY6dJXVF6g1A8hXmXAdUgTsUvYHwdEWVGpsBTNSIhImvVmIdVGH8XEmQxo/6/JwFsGOudL6DYvSEEVdSBAAcdjOA7QHKRYeWuPIqAsJNqLk8BuTXgzlCxOxIUN4sMPbFqESm6/cgSxhKsAzxLNFADtIDc/XBNojVAbxeIU6D+afHTPZNdQGjgozzxFjDCkZL0PzwXXsXJpvlZ+g60Y+Q4DoF+Jc7ThRIUGBgiGD1Y6ExQYyBMEgTOFIqxxIcJjOhwUaRYJTdR5MKDORbqFgIW+0/sIJAHva70L1wD74ISV7lJEy9O+Q0uA86Kfz2DsM1uv+wWtpb4HCfX9g3Wt21ABZaKrLLKEgMBuLazr5dqcxuq7+FJDdBVYbvSmVBJ+yfn/S+g33hMDlCZT8MsJLAMZ9xGSu0OWeqkHfbUCVX261i/v5lyPfjZQ8H0Bklzvy4T4w/rhvM/4mbdJtgZCMvRbPfxGlPn/0AyFM4W9VQ6LH81tBAfmDDO/RbZuv4g3VbYW/8QwSxjY6O3IAz/9D6/4zKZUEx+nf4fgLbxEUbEfABIK0AhKIhxJIBtIWjP9hrxsktet0PnhoD6VUQCW5VefBX+MZhb0Pkw6qE6QAqNwv6bZcIS4AFhDshpi48L5Cbf+T9TskHKiKWGAIqAVJgNwRvAtJIXzaCe77At033HtN48CwOOAQeUv3A5IRgrOhml2v64PjwEiyh1EwnjAl2Pto0eczrN/PCLXVWN9jJ/LHCY4MeHRP0imm+x4uVx3wHFpb7eLfrs9zHqzbMPkQNuVyPJl7QR0Yf0iVGBs8V4TJQCWFycCQzGG6TfP8kRe2PozbvuQGrsMEAckbzxYB4+dQEBOIv7BVYp69rvN0IV96h6Qa3r9sXpwYP0iBJ4V+x3z/l75vmFDC+9QFAoFAIBAIBAKBQCAQCAQCgUAgEAgEAoFAIBAItivckLuDSp7XsE8Xxj20ShxLLYuPo0tfDYc81bauHTntS5kjd91MvRMIBHVC6/ymlNHrOorlX0utvkCQrSGqNGpT8EeKF93AyQ++vqX7QZRVcDXFCs+nzHfsxZtGmfl/p1jxdZTZM9iul9l7L4olLqH0/HsoI/9Byipsw/lOjuxLRuFJlJW4XvXHJNTZqkezzX7fdUFm9/0pu2w85VRMpNu+CMfF1Q7p+ddTh76TeGxf2Ey9cwN9jiWuTRpTO2UV/YMyc10nBwkEvxFkllzDi3oZte29lOIlX9Cl3fxTSjJHNmFCep3a91tG2cX+ic0Z+ZdQ2/I51L7/APp3z2CjP6SinLLB1KH/UibIK9S1VrkHU07JR1z3Qq57EbWr4HIDFvC18Ab+APGSx6hdv2Uqf/u+81TqOGQO19lqyw1ALXB77gGUXTKD2pb9zPcXTeZh3NbraCa7Oyi9MDjSK6PwRmrfZxplF728JboatJN/FnUYPFONZduKBRQvX8rju4Tbns/Pdh616z+qyhdTfdAy91B+dumUxYTfvNPm+MyrQLAF0LrwOooXe7y4PSaoldS6l3+KDEgwlnib2vX2KJ7w9wW3KfgHZZcu4UU0PJkES3biOkZQTvkmyuh5FZGXxlJGNhPjKpbk5vCCz6I2vS6gTF4QINIoxIqf4MXqUaygP5NGJkunWRQrilNmwvUVul8fkKripdP5vmpDgo1Y2upM7fps4rLB/up/88sm84vj6daeh1RRtv7Ay8iMZWbiWX7OSzjNY6n8XnUtq/AWig8OH5+1GcBzIKvgTiZengOFL6r5JBBskwAJ5pQy8RTO4b+LKKu4iK7tul+tSBD2rVjp8EoSbN5pZ8oseJfzbuI6PqNWH+otV575dIAbIMEO/bkvidf8vJxsO+INL+7CC+sizvcit/UZq6ZvMalepQgFgIoOqTG7+GHKyDtOX2OJtuCffK0TSzz+B5wgHcVLnuR0KUspN3E9Xbmv3Zi4b6xU89EuzADxosf498/4/nghF1zO9UxLIsHbexzO/f0PZVd8wAs+l2IlL1ProgtVu5AcY0WPcx0jWXrk+youVf+H2SGz52lcz5NK/Te4+KPdOO9V3K9XVV34izE3fcLfzILbmEzvp9Z5Z/KL536Kl/XgMm9S6y/+rIjHCT2WmYlz+HnO4nudxGN2mLr2r55H8v/vU+3GEs253S7czyuoTe4xTJaP87/TK6uBqSOz6AHu853qGaO99IIzuOwzqr/tyrvyOLWnFnkH8ph14Hvll1nJen4mw1nifbxy/AWCbQogwbYVLAkWlfPk/oTJZYFamIrYIkgwp+Jbyvz8r9Si8ChqkXsUtfz0OF4soytJUBFP4ileCOuZVKcr1a9N7r7Ri1RDkWA/bq+oC7X46KjK+kGiULkz8jty27O5D6u47h95gbFqV/YL5RQ/pQhSSWqJCs6zlNu/TNUJ4ognurAav4qyerVTCx+qafs+3E7xJF6oP7EEPJPrW8sENl/1VZXjBZ9dXsREtY7TIiaEnzn/DF7QK7j9gAQzCtoq9T2ndBzf/xjOs4JJapYinJZMxPHEbC6zWknbKBtPzKP0vPP599vpjv4Y926qHhBgrOBh7ucCVUd26Y/cr+Wsvs7ncveo5+Hb93qr+89KTOSyPBYlc7nvGymn92BFXFUhM+8cNX45pZN9EmTcnvc3atd3Lr8MBnO94+mOAWv5vjv6po8++PegoHzhadzWAs43Vdl70/NO4Gcwma+t4Tq/576P4/9XKAk3Xvwl93Ulj7XH97pKjUNGgetj8wLBVoYhwXhpHhPA6bzg5/HCGqq8lpAwUkiQ1al40XpeTIu53KLKFCvaoCQ/pQ4zsEDaln2proFIsovG8yK6J8lxEgZIEO1ll6z264VtsM98Si86lzI+P0tJqiCgjIKbuQ/7UJueZ7NkNoPJZxkTxXV0wwcHKJKA3Ss9PyDBWOGHSjUHYSmJiEmwbTnfV8kcJUmmK4fP64rE4yWfqnJQIXOYXEAMbXqep9TWWOGbSqKrJEGuC86j1vl/pjOZhEHUmQV3cd83cPmXlDR9Q+6hTFgfqPuKsRTVqvhgP1/+7dShb0CCWb2u5PaWcbnJagyv+XBvJqbLfKJjIoyzdNkybz++Vs79xItikLI1ZuSeys/nGy67kknutiqftYsE2xScx/+fx3Ws4z59wZLd1ZTOLx6QYE7FWq53YGV53Gt2CZN06RQlfWcVZquXSaxoiCJojDWcZ3gJYkzj+c9wX9fw/b+lJGYQvUCwzaGSBIsLlIqTVfKBmvzpeVfz5H7DTYIsfeSUdmEV8A2Vcsrf5PJ8rSwgQaiTrfN/z5Lgf7nMd5x/lSKi7JJP6Kr393D2RdkEsagSY5mk/Hrb9n5NSVSQhvzfPlNSEYCQlVjRayyJbFBOHGWIryEJoq6s4l5qwQIg1nZ9uJ6icvX/rMJXFUmhfrSjxirvFL73ZdyeRYIIcym6VUmjUOMzCwqYJNez9PORJsEdePxe9/te0rbyXsMkmF30vLKHol3TJ6X+F37MxLuOSfq/TFAHKRJE/SAgfwx259+6KUk2o6BDlc86igSzmQSzy2YwsQanCsVqQIJ4geSUs5RbspjHiVVhlqJhg6x8NvkP8tzi3wteqHxmAsE2h2QSbKzsZTkVP/Ei7suLIpfaVbhsgsMU4RigXKwksAmGkZl7BGUkHuI2WILsvYRa9/x7Sh7A2ATjha+m/BZnkgFpxBNvBRdZvc4seJT7tIGlzB4ssR3pq4ssUbUp8M/ta6HUzG6pJKgJrrKPva7h+zIkyCpz6f+0k6ZTZR5Ig5AejU3wBl7wIPWcstVMoF8p22JWosS3g3GbauFjbPhloki3pF3QXogE40XvK1NArPjhyjwon1X4EpMW96vgLbr140O4fpYES5erUCVVD5N8RuF79SJBJf1XjEiy8xoSzC4bVGmXzeh5Ot/vL4oEoQ5f3JnHtvg+/v/X/guO+5BdVKgIEiSYVfCQIkE4RoQEBdsswiSIRZWVeIGJhSdvYgFP7jp4hxnNtR3PALF+8cRCliyXU5te4Q8f+ah0jFjkZJBVlM393MSk0E8FGas2WHKNJ77gPm5QxnmQFEgMNrOM/H/77cI7ymo5iCpMgvHiVyrrTyZB7kviaU2U3SsdE7FezbmdNZXqcFbiSqWKZxaXKaLH/WYlWqr+ZCU+9e/fIsFYUcegvRQSfMyXuvnFYxw9UPlhq80uX6u8uXA4KBLkNtG2qmdzkWD5ULq5R3AmYmavi7mdtUzo3yqJFA6tWGELJssVlSToP4PGdMN7+1IGHCvQBio28r/PqiTBnIo1XO4VOqaeweUCwRZDmAQB2POyWcVRYTOldSHBRqy6XcTS5IsqBAMe2IzC7qzWbaDs4plKTXahKhJswX3KKZ2qpLysxHPK8RAvuIOvLWOSm88L7jxfNUx8yAuaF2JBMbf5Nya1J31HSmntSBC2MdgmEU6SkX+3spHF4HQpDWyCyBMvW8H9/VIRTDpIMjFM2RthXzPkAYJWkmBBoQoVghQdJsHWuWdyvbO4vYXcTice67P5Hh9lwlmhPNLwJiub4K9Fgnx/sQQTXtFyvvcsikP1ZWkfNt5KdfjT41TQ9+35J/JY/FOZROAMa1/+J3Xfmfx8ssuZBIu/VHOnTUHVjhuBYKsAC7ltH8SOfZYU0Bovfo4n8EJeICDDDJ33IqUK5vTtV7mIAEg8seIBqh5li2OigSewfd/5nH+9cjD46tIoZTeKQlbJIyrgOp5w7aJIU86B7PJhvjRSspHJZjUv6G8pnYnWVtniZT8ouxm8llDVsvJLVLB2rDDL9w4zqbfvu5T73Lmydkin7fosYrU+X/3fl4iforalv3BdG7kubrOY2y6ZyiTk7xhR3tqSd5V6Gi+GY2guE2I37uMUVul7KlJWdRWexgQykcuuZ2mPVfeCW5UdsUO/pUxw7/kdaN5Y2WGzy0fzS2kl17eJ728lj9tXTHKX+n1U9scCyuk9m+v3r92Qu4t22PzC+ar+xEFW4ky+Rx6bitHUsqtvzgAxti2bSvGKikp7nl/vDiosCA4q3H9O2QJ+QXyqgsXjpWMVCcZL+MXRF0S5QZkA2pbP4vt/tjImsHXu75U6nVOyTpkssgof02FSAsE2hBYfHaikk/QCfAMimKBYEJCksMuhZcJfMFiEuAYvsooTM/DSlIc0K3GBIgagZdf9FGlhq1x6fozLXEetejWrNPq74O+suLAyxi8VacpzCaktPRHj9m7ifx8d2o2Qxu2cqkJQsnrdosJGkAcxcEZ6hacy3A48y+h/Bpc1gAMnPe8iv/+Ja/3+5/+V/3+usjWqchgTlpLgTYZUhdhAqIOox/RLqYZ5pyjpLyuRoWyXsO+hD/b2O+SDEwjb2TIL4iq+McZtGscMxg7eYEicZpzxG0JSsG3Rls5dgMcZfYfd15gqzDVIb2G7HdRxEDDuv83n/rOFhIryUPNx75BIce/p/JwRu5js9EpTMZFZ+S3VzpHWeTX9BINAIBAIBAKBQCAQCAQCgUAgEAgEAoFAIBAIBAKBQCAQCAQCgUAgEAgEAoFAIBAIBAKBQCAQCAQCgUAgEAgEAoFAIBAIBAKBQCAQCAQCgUAgEAgEAoFAIGhg+H/++kRX8gBisQAAAABJRU5ErkJggg==" width="140"/>
</p>
<table cellpadding="0" cellspacing="0" style="width: 100%;" width="751">
<col width="187"/>
<col width="188"/>
<col width="188"/>
<col width="187"/>
<tr valign="top">
<td height="127" style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.1in; margin-right: 0.1in; margin-top: 0.06in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Co-Codamol</b></span></font></font></font><font color="#000000"><font face="Arial,Bold, serif"><font size="1" style="font-size: 8pt"><span style="font-style: normal"><b>®</b></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">NB</span></span></font></font></font><font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>.</b></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">
			If patient less than 50kg please prescribe Paracetamol and Codeine
			separately (see the Clinical Guideline: </span></span></font></font></font><br/>
<font color="#0000ff"><font face="Arial,Italic, serif"><font size="3" style="font-size: 12pt"><i><span style="font-weight: normal">Paracetamol
			dosing in adult patients</span></i></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">).</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.1in; margin-top: 0.55in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">PO</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.1in; margin-right: 0.2in; margin-top: 0.36in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">8/500
			</span></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">or
			</span></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">30/500</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1.00pt solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.1in; margin-top: 0.17in; margin-bottom: 0in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">4-6
			hourly.</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.1in; margin-right: 0.1in; margin-bottom: 0in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Maximum
			8 tablets of either strength within 24 hrs.</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.1in; margin-top: 0.04in">
<font color="#ff0000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Not
			to be taken in conjunction with other Paracetamol preparations.</b></span></font></font></font></p>
</td>
</tr>
</table>
<p align="left" style="line-height: 0.31in; orphans: 2; widows: 2; margin-left: 0.2in; margin-top: 0.14in; margin-bottom: 0.15in">
<font color="#0071c5"><font face="Arial,Bold, serif"><font size="4" style="font-size: 16pt"><span style="font-style: normal"><b>STRONG
OPIOIDS </b></span></font></font></font>
</p>
<table cellpadding="0" cellspacing="0" style="width: 100%;" width="751">
<col width="187"/>
<col width="188"/>
<col width="188"/>
<col width="187"/>
<tr valign="top">
<td height="73" style="border: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-top: 0.04in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Morphine
			Sulphate </b></span></font></font></font><font color="#ff0000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>*
			(see page 3 above) </b></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">(Immediate
			release) </span></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Oral
			solution 10mg/5m</span></span></font></font></font></p>
</td>
<td style="border: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">PO</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="center" style="orphans: 0; widows: 0">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">10-20mg</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-bottom: 0in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">2-4
			hourly PRN (review in 24 hrs).</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-right: 0.2in; margin-top: 0.04in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">NB</span></span></font></font></font><font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>.</b></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">
			In palliative patients consider 1 hourly PRN.</span></span></font></font></font></p>
</td>
</tr>
<tr valign="top">
<td height="42" style="border: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-right: 0.8in; margin-top: 0.04in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Morphine
			Sulphate </b></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Injection</span></span></font></font></font></p>
</td>
<td style="border: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">S/C</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">5-10mg</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Maximum
			frequency 4 hourly PRN.</span></span></font></font></font></p>
</td>
</tr>
<tr valign="top">
<td height="93" style="border: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-right: 0.8in; margin-top: 0.04in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Morphine
			Sulphate </b></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Injection</span></span></font></font></font></p>
</td>
<td style="border: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">IV</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-right: 0.1in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Titrate
			in 1-2mg </span></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">boluses</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-top: 0.04in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Administration
			and observations in </span></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">accordance
			with Clinical Guideline: </span></span></font></font></font><br/>
<font color="#0000ff"><font face="Arial,Italic, serif"><font size="3" style="font-size: 12pt"><i><span style="font-weight: normal">Administration
			of IV opioid bolus</span></i></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">.
			 </span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><u><span style="font-weight: normal">NB.</span></u></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">
			Only to be prescribed in the once only dr</span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><u><span style="font-weight: normal">ug
			</span></u></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">section
			(STAT).</span></span></font></font></font></p>
</td>
</tr>
<tr valign="top">
<td height="92" style="border: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-bottom: 0in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Morphine
			Sulphate M/R</b></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-bottom: 0in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">(Modified
			release) </span></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">1</span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="1" style="font-size: 8pt"><span style="font-style: normal"><span style="font-weight: normal">st</span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">
			line. Zomorph</span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="1" style="font-size: 8pt"><span style="font-style: normal"><span style="font-weight: normal">®</span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">
			capsules </span></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">2</span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="1" style="font-size: 8pt"><span style="font-style: normal"><span style="font-weight: normal">nd</span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">
			line. MST</span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="1" style="font-size: 8pt"><span style="font-style: normal"><span style="font-weight: normal">®</span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">
			tablets (in patients</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">who
			need  5 mg dose only)</span></span></font></font></font></p>
</td>
<td style="border: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-bottom: 0in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">PO</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-top: 0.35in"><br/>
</p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in">
<font color="#ff0000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>**</b></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-top: 0.04in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">12
			hourly </span></span></font></font></font><br/>
<font color="#ff0000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>**</b></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Dosing
			requires total analgesic assessment prior to starting, contact
			Adult Acute Pain Service for advice.</span></span></font></font></font></p>
</td>
</tr>
</table>
<p style="line-height: 0.13in; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>
</p>
<table cellpadding="0" cellspacing="0" style="width: 100%;" width="751">
<col width="187"/>
<col width="188"/>
<col width="188"/>
<col width="187"/>
<tr valign="top">
<td height="59" style="border: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-right: 0.2in; margin-top: 0.04in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Oxycodone
			Hydrochloride </b></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">(Immediate
			release) </span></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Oral
			solution 5 mg/5ml</span></span></font></font></font></p>
</td>
<td style="border: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">PO</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="center" style="orphans: 0; widows: 0">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">2.5-10mg</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-right: 0.1in; margin-top: 0.04in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">2-4
			hourly titrate (review in 24 hours) PRN. NB</span></span></font></font></font><font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>.</b></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">
			In palliative patients consider 1 hourly PRN.</span></span></font></font></font></p>
</td>
</tr>
<tr valign="top">
<td height="42" style="border: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-right: 0.2in; margin-top: 0.04in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Oxycodone
			Hydrochloride </b></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Injection</span></span></font></font></font></p>
</td>
<td style="border: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">S/C</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">5mg</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Maximum
			frequency 4 hourly PRN.</span></span></font></font></font></p>
</td>
</tr>
<tr valign="top">
<td height="93" style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-right: 0.2in; margin-top: 0.04in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Oxycodone
			Hydrochloride </b></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Injection</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">IV</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Titrate
			in 1 - 2mg </span></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">boluses</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in">
<table cellpadding="0" cellspacing="0" style="width: 100%;" width="331">
<col width="165"/>
<col width="165"/>
<tr valign="top">

<td style="border: none; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.03in; margin-top: 0.04in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Administration
						and observations in </span></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">accordance
						with Clinical Guideline: </span></span></font></font></font><br/>
<font color="#0000ff"><font face="Arial,Italic, serif"><font size="3" style="font-size: 12pt"><i><span style="font-weight: normal">Administration
						of IV opioid bolus</span></i></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">.
						</span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><u><span style="font-weight: normal">NB.</span></u></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">
						Only to be prescribed in the once only dru</span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><u><span style="font-weight: normal">g
						se</span></u></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">ction
						(STAT).</span></span></font></font></font></p>
</td>
</tr>
</table>
<p style="line-height: 0.01in; orphans: 0; widows: 0; margin-bottom: 0in">
<br/>
</p>
</td>
</tr>
<tr valign="top">
<td height="73" style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1.00pt solid #000000; padding: 0in"><p align="left" style="line-height: 0.19in; orphans: 0; widows: 0; margin-left: 0.08in; margin-right: 0.2in; margin-top: 0.04in; margin-bottom: 0in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Oxycodone
			Hydrochloride M/R </b></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">(Modified
			Release)</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1.00pt solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="line-height: 120%; orphans: 0; widows: 0; margin-left: 0.08in; margin-bottom: 0in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">PO</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="line-height: 0.23in; orphans: 0; widows: 0; margin-left: 0.08in; margin-bottom: 0in">
<font color="#ff0000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>**</b></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="line-height: 105%; orphans: 0; widows: 0; margin-left: 0.08in; margin-bottom: 0in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">12
			hourly </span></span></font></font></font><br/>
<font color="#ff0000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">**</span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Requires
			total analgesic assessment prior to starting, contact Adult Acute
			Pain Service for advice.</span></span></font></font></font></p>
</td>
</tr>
</table>
<p style="line-height: 0.11in; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>
</p>
<table cellpadding="0" cellspacing="0" style="width: 100%;" width="751">
<col width="187"/>
<col width="188"/>
<col width="188"/>
<col width="187"/>
<tr valign="top">
<td height="56" style="border: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Fentanyl</b></span></font></font></font></p>
</td>
<td style="border: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">S/C</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">12.5
			- 25 </span></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">microgram</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 0.85pt solid #000000; padding: 0in">
<table cellpadding="0" cellspacing="0" style="width: 100%;" width="330">
<col width="165"/>
<col width="165"/>
<tr valign="top">

<td style="border: none; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.03in; margin-bottom: 0in">
<font color="#ff0000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Not
						for IV bolus unless in recovery</b></span></font></font></font><font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>.</b></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.03in; margin-top: 0.04in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">See
						Clinical </span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">G</span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">uideline:
						</span></span></font></font></font><font color="#0000ff"><font face="Arial,Italic, serif"><font size="3" style="font-size: 12pt"><i><span style="font-weight: normal">Analgesic
						Prescribing in Adults with Renal Impairment.</span></i></font></font></font></p>
</td>
</tr>
</table>
<p style="line-height: 0.01in; orphans: 0; widows: 0; margin-bottom: 0in">
<br/>
</p>
</td>
</tr>
<tr valign="top">



</tr>
<tr valign="top">
<td height="93" style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="line-height: 0.19in; orphans: 0; widows: 0; margin-left: 0.08in; margin-right: 0.2in; margin-top: 0.04in; margin-bottom: 0in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Opioid
			Substitution Therapy: </span></span></font></font></font><font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Methadone
			</b></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">or
			</span></span></font></font></font><br/>
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Buprenorphine
			(Subutex</b></span></font></font></font><font color="#000000"><font face="Arial,Italic, serif"><font size="1" style="font-size: 8pt"><i><span style="font-weight: normal">®</span></i></font></font></font><font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>)</b></span></font></font></font></p>
</td>
<td colspan="3" style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="line-height: 0.19in; orphans: 0; widows: 0; margin-left: 0.08in; margin-right: 0.5in; margin-top: 0.04in; margin-bottom: 0in">
<font color="#ff0000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>N.B.
			Confirm dose with prescriber in community. </b></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">See
			Clinical Procedure: Management of opioid dependent patients (DMS).</span></span></font></font></font></p>
<p align="left" style="line-height: 0.19in; orphans: 0; widows: 0; margin-left: 0.08in; margin-right: 0.5in; margin-top: 0.04in; margin-bottom: 0in">
<font color="#ff0000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Not
			for FP10 prescription or TTA</b></span></font></font></font><font color="#ff0000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">,
			</span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">seek
			advice from the Substance Misuse Service (bleep: 5129).</span></span></font></font></font></p>
</td>
</tr>
</table>
<p style="line-height: 0.11in; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>
</p>
<table cellpadding="0" cellspacing="0" style="width: 100%;" width="751">
<col width="250"/>
<col width="250"/>
<col width="250"/>
<tr valign="top">
<td height="77" style="border-top: 1px solid #000000; border-bottom: none; border-left: none; border-right: none; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.13in; margin-top: 0.66in">
<font color="#a9a9a9"><font face="Arial Narrow, serif"><font size="2" style="font-size: 10pt"><span style="font-style: normal"><span style="font-weight: normal">Version
			1:2 From: Sep 20 – To: Sep 23</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: none; border-left: none; border-right: none; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.32in; margin-top: 0.66in">
<font color="#a9a9a9"><font face="Arial Narrow, serif"><font size="2" style="font-size: 10pt"><span style="font-style: normal"><span style="font-weight: normal">Author(s):
			Adult Acute Pain Service</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: none; border-left: none; border-right: none; padding: 0in"><p align="right" style="orphans: 0; widows: 0; margin-right: 0.16in; margin-top: 0.66in">
<font color="#a9a9a9"><font face="Arial Narrow, serif"><font size="2" style="font-size: 10pt"><span style="font-style: normal"><span style="font-weight: normal">Page
			4 of 6</span></span></font></font></font></p>
</td>
</tr>
</table>
<p style="line-height: 0.01in; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>
</p>
<p style="line-height: 0.01in; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>
</p>
<p style="line-height: 0.01in; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>
</p>
<p style="line-height: 0.01in; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>
</p>
</body></div><div style="position: relative;"><body dir="ltr" lang="en-US" link="#000080" vlink="#800000"><p style="line-height: 0.02in; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>
</p>
<p align="right" style="line-height: 100%; orphans: 2; widows: 2; margin-right: 0.26in; margin-top: 0.03in; margin-bottom: 0.07in">
<img align="bottom" border="0" height="59" hspace="12" name="Picture 1" src="data:image/png;base64,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" width="140"/>
</p>
<table cellpadding="0" cellspacing="0" style="width: 100%;" width="751">
<col width="749"/>
<tr>
<td bgcolor="#fffff3" height="73" style="background: #fffff3; border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in" valign="top"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.1in; margin-right: 0.3in; margin-top: 0.01in">
<font color="#ff0000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>N.B.
			Lidocaine patch and Fentanyl patch are not recommended in acute
			pain -specialist management only, please seek advice from Adult
			Acute Pain Service or Supportive &amp; Palliative care before
			prescribing.</b></span></font></font></font></p>
</td>
</tr>
</table>
<p align="left" style="line-height: 0.31in; orphans: 2; widows: 2; margin-left: 0.3in; margin-top: 0.14in; margin-bottom: 0.14in">
<font color="#0071c5"><font face="Arial,Bold, serif"><font size="4" style="font-size: 16pt"><span style="font-style: normal"><b>ANTIEMETICS</b></span></font></font></font></p>
<table cellpadding="0" cellspacing="0" style="width: 100%;" width="751">
<col width="187"/>
<col width="188"/>
<col width="188"/>
<col width="187"/>
<tr valign="top">
<td height="73" style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-right: 1.2in; margin-top: 0.21in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Ondansetron
			</b></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">1</span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="1" style="font-size: 8pt"><span style="font-style: normal"><span style="font-weight: normal">st</span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">
			line</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="center" style="orphans: 0; widows: 0; margin-top: 0.26in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">IV/PO</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-top: 0.26in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">4mg</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-bottom: 0in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">12
			hourly (slow IV over 3-5 minutes).</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-right: 0.1in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><u><span style="font-weight: normal">NB</span></u></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">.
			Prescribe a pre-emptive laxative if the </span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><u><span style="font-weight: normal">pat</span></u></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">ient
			is requiring administration of </span></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Ondansetron.</span></span></font></font></font></p>
</td>
</tr>
<tr valign="top">
<td height="93" style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-right: 0.8in; margin-top: 0.04in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Prochlorperazine
			</b></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">2</span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="1" style="font-size: 8pt"><span style="font-style: normal"><span style="font-weight: normal">nd</span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">
			line</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">IM
			</span></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Oral
			</span></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Buccal</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-right: 0.1in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">STAT
			</span></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">12.5mg</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-right: 0.1in; margin-bottom: 0in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">To
			be followed by an oral dose of 5mg after six hours if required.</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-right: 2in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">5mg
			–10mg TDS </span></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">or
			</span></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">3mg
			- 6mg BD</span></span></font></font></font></p>
</td>
</tr>
<tr valign="top">
<td height="39" style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-right: 1.5in; margin-top: 0.04in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Cyclizine
			</b></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">3</span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="1" style="font-size: 8pt"><span style="font-style: normal"><span style="font-weight: normal">rd</span></span></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">
			line</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-right: 0.1in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">IV/IM/
			PO</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-top: 0.08in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">50mg</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-top: 0.08in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">8
			hourly (slow IV over 3-5 minutes).</span></span></font></font></font></p>
</td>
</tr>
</table>
<p align="left" style="line-height: 0.3in; orphans: 2; widows: 2; margin-left: 0.2in; margin-top: 0.13in; margin-bottom: 0.14in">
<font color="#0071c5"><font face="Arial,Bold, serif"><font size="4" style="font-size: 16pt"><span style="font-style: normal"><b>NALOXONE</b></span></font></font></font></p>
<table cellpadding="0" cellspacing="0" style="width: 100%;" width="751">
<col width="249"/>
<col width="250"/>
<col width="249"/>
<tr valign="top">
<td bgcolor="#fffff3" height="148" style="background: #fffff3; border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-right: 0.4in; margin-bottom: 0in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Required
			for all patients receiving opioids via IV or neuraxial route.</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-right: 0.1in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Consider
			Naloxone prescription when prescribing any weak/strong opioids
			especially for patients with renal </span></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">impairment
			and/or the elderly.</span></span></font></font></font></p>
</td>
<td bgcolor="#fffff3" style="background: #fffff3; border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">IV</span></span></font></font></font></p>
</td>
<td bgcolor="#fffff3" style="background: #fffff3; border-top: 1px solid #000000; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-top: 0.04in; margin-bottom: 0in">
<font color="#ff0000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Respiratory
			Depression </b></span></font></font></font><font color="#ff0000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">(respiratory
			rate 8 or below).</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in; margin-bottom: 0in">
<font color="#ff0000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Dilute
			400 micrograms (1ml) of Naloxone in 3 ml Normal Saline 0.9% to a
			concentration of 100 micrograms per ml.</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.08in">
<font color="#ff0000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Administer
			100 micrograms (1ml) IV. Repeat at 2 minute intervals until
			respiratory rate 12 or above per minute and sedation score is 2</span></span></font></font></font></p>
</td>
</tr>
</table>
<p align="right" style="line-height: 120%; orphans: 2; widows: 2; margin-right: 3.03in; margin-bottom: 0in">
<font color="#ff0000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">or
less.</span></span></font></font></font></p>
<table cellpadding="0" cellspacing="0" style="width: 100%;" width="751">
<col width="749"/>
<tr>
<td height="193" style="border-top: 1.50pt solid #000000; border-bottom: 1.50pt solid #000000; border-left: none; border-right: 1.50pt solid #000000; padding: 0in" valign="top"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.05in; margin-top: 0.09in; margin-bottom: 0in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>Prior
			to discharge from recovery to ward, all postoperative patients
			must have prescribed:</b></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.54in; text-indent: -0.25in; margin-top: 0.04in; margin-bottom: 0in">
<font color="#000000"></font><font color="#000000"> <font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">An
			appropriate analgesic regime including a strong opioid PRN for
			severe breakthrough pain (e. g. Morphine Sulphate oral solution)
			</span></span></font></font></font><font color="#000000"><font face="Arial,Italic, serif"><font size="3" style="font-size: 12pt"><i><span style="font-weight: normal">unless
			</span></i></font></font></font><font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">day-case
			patient or a strong opioid is contraindicated.</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.3in; margin-bottom: 0in">
<font color="#000000"></font><font color="#000000"> <font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Naloxone
			if patient is prescribed: Patient Controlled Analgesia (PCA),
			Epidural Fentanyl or if </span></span></font></font></font> <font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">an
			intrathecal opioid has been used.</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.3in; margin-bottom: 0in">
<font color="#000000"></font><font color="#000000"> <font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Antiemetics
			e.g. Ondansetron, Prochlorperazine or Cyclizine.</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.3in"><font color="#000000"></font><font color="#000000">
<font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">NB:
			Pre-printed prescription labels can be found in BRI: Hey groves
			theatres recovery, QDU </span></span></font></font></font> <font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">recovery,
			general ITU and also in StMH recovery/theatres.</span></span></font></font></font></p>
</td>
</tr>
</table>
<p style="line-height: 0.1in; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>
</p>
<table cellpadding="0" cellspacing="0" style="width: 100%;" width="751">
<col width="374"/>
<col width="374"/>
<tr valign="top">
<td height="122" style="border-top: 1px solid #0071c5; border-bottom: 1px solid #0071c5; border-left: 1px solid #0071c5; border-right: 1px solid #0071c5; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-top: 0.02in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>REFERENCES</b></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #0071c5; border-bottom: 1px solid #0071c5; border-left: 1px solid #0071c5; border-right: 1px solid #0071c5; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-right: 0.1in; margin-top: 0.05in; margin-bottom: 0in">
<br/>
</p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-top: 0.05in; margin-bottom: 0in">
<br/>
</p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-top: 0.05in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">C).</span></span></font></font></font></p>
</td>
</tr>
</table>
<p style="line-height: 1.23in; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>
</p>
<table cellpadding="0" cellspacing="0" style="width: 100%;" width="751">
<col width="250"/>
<col width="250"/>
<col width="250"/>
<tr valign="top">
<td height="26" style="border-top: 1px solid #000000; border-bottom: none; border-left: none; border-right: none; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.09in; margin-top: 0.13in">
<font color="#a9a9a9"><font face="Arial Narrow, serif"><font size="2" style="font-size: 10pt"><span style="font-style: normal"><span style="font-weight: normal">Version
			1:2 From: Sep 20 – To: Sep 23</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: none; border-left: none; border-right: none; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.32in; margin-top: 0.13in">
<font color="#a9a9a9"><font face="Arial Narrow, serif"><font size="2" style="font-size: 10pt"><span style="font-style: normal"><span style="font-weight: normal">Author(s):
			Adult Acute Pain Service</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: none; border-left: none; border-right: none; padding: 0in"><p align="right" style="orphans: 0; widows: 0; margin-right: 0.12in; margin-top: 0.13in">
<font color="#a9a9a9"><font face="Arial Narrow, serif"><font size="2" style="font-size: 10pt"><span style="font-style: normal"><span style="font-weight: normal">Page
			5 of 6</span></span></font></font></font></p>
</td>
</tr>
</table>
<p style="line-height: 0.01in; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>
</p>
<p style="line-height: 0.01in; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>
</p>
<p style="line-height: 0.01in; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>
</p>
</body></div><div style="position: relative;"><body dir="ltr" lang="en-US" link="#000080" vlink="#800000"><p style="line-height: 0.02in; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>
</p>
<p align="right" style="line-height: 100%; orphans: 2; widows: 2; margin-right: 0.26in; margin-top: 0.03in; margin-bottom: 0in">
<img align="bottom" border="0" height="59" hspace="12" name="Picture 1" src="data:image/png;base64,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" width="140"/>
</p>
<table cellpadding="7" cellspacing="0" style="width: 100%;" width="751">
<col width="361"/>
<col width="361"/>
<tr>

</tr>
<tr valign="top">
<td height="38" style="border-top: 1px solid #0071c5; border-bottom: 1px solid #0071c5; border-left: 1px solid #0071c5; border-right: 1px solid #0071c5; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-top: 0.05in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>AUTHORISING
			BODY</b></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #0071c5; border-bottom: 1px solid #0071c5; border-left: 1px solid #0071c5; border-right: 1px solid #0071c5; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-top: 0.02in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Clinical
			Effectiveness Group, January 2015.</span></span></font></font></font></p>
</td>
</tr>
<tr valign="top">
<td bgcolor="#ffffff" height="67" style="background: #ffffff; border: 1px solid #0071c5; padding: 0in"><p align="center" style="orphans: 0; widows: 0; margin-right: 0.5in; margin-top: 0.05in">
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>SAFETY/
			</b></span></font></font></font><br/>
<font color="#000000"><font face="Arial,Bold, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><b>QUERIES</b></span></font></font></font></p>
</td>
<td bgcolor="#ffffff" style="background: #ffffff; border-top: 1px solid #0071c5; border-bottom: 1px solid #0071c5; border-left: 1px solid #0071c5; border-right: 1px solid #0071c5; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in; margin-right: 1in; margin-top: 0.01in; margin-bottom: 0in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Adult
			Acute Pain Service (bleep: 3916) Monday to Friday 8:00-17:00 Out
			of hours: 1st on-call anaesthetist (bleep: 2188). </span></span></font></font></font><br/>
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Substance
			misuse service (bleep: 5129).</span></span></font></font></font></p>
<p align="left" style="orphans: 0; widows: 0; margin-left: 0.07in">
<font color="#000000"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><span style="font-style: normal"><span style="font-weight: normal">Medicines
			information (extension: 29282 or bleep: 2597).</span></span></font></font></font></p>
</td>
</tr>
</table>
<p style="line-height: 6.2in; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>
</p>
<table cellpadding="0" cellspacing="0" style="width: 100%;" width="751">
<col width="250"/>
<col width="250"/>
<col width="250"/>
<tr valign="top">
<td height="26" style="border-top: 1px solid #000000; border-bottom: none; border-left: none; border-right: none; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.09in; margin-top: 0.13in">
<font color="#a9a9a9"><font face="Arial Narrow, serif"><font size="2" style="font-size: 10pt"><span style="font-style: normal"><span style="font-weight: normal">Version
			1:2 From: Sep 20 – To: Sep 23</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: none; border-left: none; border-right: none; padding: 0in"><p align="left" style="orphans: 0; widows: 0; margin-left: 0.32in; margin-top: 0.13in">
<font color="#a9a9a9"><font face="Arial Narrow, serif"><font size="2" style="font-size: 10pt"><span style="font-style: normal"><span style="font-weight: normal">Author(s):
			Adult Acute Pain Service</span></span></font></font></font></p>
</td>
<td style="border-top: 1px solid #000000; border-bottom: none; border-left: none; border-right: none; padding: 0in"><p align="right" style="orphans: 0; widows: 0; margin-right: 0.12in; margin-top: 0.13in">
<font color="#a9a9a9"><font face="Arial Narrow, serif"><font size="2" style="font-size: 10pt"><span style="font-style: normal"><span style="font-weight: normal">Page
			6 of 6</span></span></font></font></font></p>
</td>
</tr>
</table>
<p style="line-height: 0.01in; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>
</p>
<p style="line-height: 0.01in; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>
</p>
</body></div></body></html>